NCT02954315

Brief Summary

Investigators hypothesize that regular consumption of almonds will augment the long chain fatty acid profile and the alpha-tocopherol levels, improve the skin barrier function, and improve the appearance of facial wrinkles in post-menopausal women.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
31

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Oct 2016

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 25, 2016

Completed
7 days until next milestone

First Submitted

Initial submission to the registry

November 1, 2016

Completed
2 days until next milestone

First Posted

Study publicly available on registry

November 3, 2016

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 30, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 30, 2018

Completed
Last Updated

October 17, 2018

Status Verified

October 1, 2018

Enrollment Period

1.5 years

First QC Date

November 1, 2016

Last Update Submit

October 15, 2018

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change in wrinkle depth

    16 weeks

Secondary Outcomes (4)

  • Change in clinical appearance of facial wrinkles on lateral canthi

    16 weeks

  • Change in facial sebum production through the use of a Sebumeter

    16 weeks

  • Change in serum and sebum lipid profiles

    16 weeks

  • Change in the serum and sebum lipid profile for assessment of long chain/short chain fatty acid ratios and the NS ceramide content

    16-weeks

Study Arms (2)

Almond arm

EXPERIMENTAL

The almond dose will be provided as 20% of total energy (20% E) in the diet. This dose was selected based on a previous randomized trial examining lipid parameters in response to 0, 10%, and 20% E as dietary almonds and a recent meta-analysis of intervention trials.

Other: Almonds

Western diet Snack (Granola bar + Pretzels)

NO INTERVENTION

The control snack will be a typical western diet snack (see Table 1). The calorie-matched control snack will be commercially available individually wrapped food products such as a small granola bar + pretzels.

Interventions

AlmondsOTHER
Almond arm

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Postmenopausal women
  • Fitzpatrick skin types 1 and 2
  • Able to follow dietary intervention and attend all study visits

You may not qualify if:

  • Those with a nut allergy
  • Smoking:
  • Current smokers
  • Those that have smoked within the past year
  • Former smokers with greater than a 20 pack-year history of smoking within the past 20 years will be excluded.
  • Those with an autoimmune photosensitive condition or a known genetic condition with a deficiency in collagen production (such as Ehler-Danlos)
  • Those that already obtain 20% of their energy intake from nut consumption
  • Those with implausible reported energy intakes of \<1,000 kcal/d or \>3,000 kcal/d
  • Individuals who are unwilling to discontinue high antioxidant supplements and daily food sources listed below, during the washout and intervention.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

UC Davis Department of Dermatology, Clinical Trials Unit

Sacramento, California, 95816, United States

Location

Related Publications (1)

  • Alasalvar C, Bolling BW. Review of nut phytochemicals, fat-soluble bioactives, antioxidant components and health effects. Br J Nutr. 2015 Apr;113 Suppl 2:S68-78. doi: 10.1017/S0007114514003729.

    PMID: 26148924BACKGROUND

Study Officials

  • Raja K Sivamani, M.D.

    UC Davis

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 1, 2016

First Posted

November 3, 2016

Study Start

October 25, 2016

Primary Completion

April 30, 2018

Study Completion

April 30, 2018

Last Updated

October 17, 2018

Record last verified: 2018-10

Locations